“…14 Retrospective observational studies have suggested that IVIG decrease mortality and duration of invasive mechanical ventilation in COVID-19-associated ARDS. [15][16][17][18][19] Further more, it has been reported in China that about a third of patients with COVID-19 and ARDS have been treated with IVIG, without the specific effect of IVIG being evaluated. [20][21][22] However, because of the cost and scarcity of IVIGs, which is currently indicated in various autoimmune and inflammatory diseases, showing the efficacy and safety of IVIG in patients who are critically ill with COVID-19 is needed to explore IVIG therapy as a viable treatment option.…”